# Single/ Multiple-Dose Study of E6007 in Healthy Japanese Male Subjects

> **NCT02268838** · PHASE1 · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** E6007
- **DRUG:** E6007 matching placebo

## Key facts

- **NCT ID:** NCT02268838
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-07
- **Final completion:** 2015-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02268838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02268838, "Single/ Multiple-Dose Study of E6007 in Healthy Japanese Male Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02268838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*